Cargando…
Epigenetic reprogramming of fallopian tube fimbriae in BRCA mutation carriers defines early ovarian cancer evolution
The exact timing and contribution of epigenetic reprogramming to carcinogenesis are unclear. Women harbouring BRCA1/2 mutations demonstrate a 30–40-fold increased risk of high-grade serous extra-uterine Müllerian cancers (HGSEMC), otherwise referred to as ‘ovarian carcinomas', which frequently...
Autores principales: | Bartlett, Thomas E., Chindera, Kantaraja, McDermott, Jacqueline, Breeze, Charles E., Cooke, William R., Jones, Allison, Reisel, Daniel, Karegodar, Smita T., Arora, Rupali, Beck, Stephan, Menon, Usha, Dubeau, Louis, Widschwendter, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4890182/ https://www.ncbi.nlm.nih.gov/pubmed/27216078 http://dx.doi.org/10.1038/ncomms11620 |
Ejemplares similares
-
Non-Surgical Cancer Risk Reduction in BRCA1 Mutation Carriers: Disabling the Remote Control
por: Widschwendter, Martin, et al.
Publicado: (2020) -
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
por: Widschwendter, Martin, et al.
Publicado: (2015) -
The DNA methylome of cervical cells can predict the presence of ovarian cancer
por: Barrett, James E., et al.
Publicado: (2022) -
Proportional vascularization along the fallopian tubes and ovarian fimbria: assessment by confocal microtomography
por: Castro, Pedro Teixeira, et al.
Publicado: (2020) -
Fimbriae reprogram host gene expression – Divergent effects of P and type 1 fimbriae
por: Ambite, Ines, et al.
Publicado: (2019)